Literature DB >> 11929265

Ru(II) and Os(II) nucleosides and oligonucleotides: synthesis and properties.

Dennis J Hurley1, Yitzhak Tor.   

Abstract

A general and versatile method for the site-specific incorporation of polypyridine Ru(II) and Os(II) complexes into DNA oligonucleotides using solid-phase phosphoramidite chemistry is reported. Novel nucleosides containing a [(bpy)(2)M(3-ethynyl-1,10-phenanthroline)](2+) (M = Ru, Os) metal center covalently attached to the 5-position in 2'-deoxyuridine are synthesized, and their electrochemical as well as photophysical properties are studied. The Ru(II) nucleoside exhibits a rather long-lived excited state in phosphate buffer pH 7.0 (tau = 1.08 micros) associated with a relatively high emission quantum efficiency (phi = 0.051). The solvent dependence of the absorption and emission spectra is consistent with an emissive MLCT state where charge localization takes place on the extended heterocycle-linked phenanthroline. In contrast, the Os(II)-containing nucleoside is quite nonemissive in aqueous environment (tau = 0.027 micros, phi = 1 x 10(-4)). The metal-containing nucleosides are converted into their phosphoramidites and are utilized for the high-yield preparation of modified oligonucleotides. The novel oligonucleotides, characterized by absorption and emission spectroscopy, enzymatic digestion, and electrophoresis, form stable duplexes. Circular dichroism spectra confirm that the global conformation of the double helix is not altered by the presence of these polypyridyl complexes in the major groove. Metal-containing phosphoramidites with predetermined absolute configuration at the octahedral coordination center are synthesized and utilized for the synthesis of diasteromerically pure metal-containing DNA oligonucleotides. Emission spectroscopy suggests a higher protection of the Delta metal center from the bulk solvent and better accommodation within the major groove.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11929265     DOI: 10.1021/ja0123103

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  8 in total

1.  Synthesis, characterization luminiscence studies and microbial activity of ethylenediamine ruthenium (II) complexes with dipyridophenazine ligands.

Authors:  Mynam Shilpa; Penumaka Nagababu; Y Praveen Kumar; J Naveena Lavanya Latha; M Rajender Reddy; K S Karthikeyan; Nazar Md Gabra; Sirasani Satyanarayana
Journal:  J Fluoresc       Date:  2010-12-22       Impact factor: 2.217

2.  Rigid cyanine dye nucleic acid labels.

Authors:  Adrian Fegan; Pravin S Shirude; Shankar Balasubramanian
Journal:  Chem Commun (Camb)       Date:  2008-03-26       Impact factor: 6.222

Review 3.  Fluorescent analogs of biomolecular building blocks: design, properties, and applications.

Authors:  Renatus W Sinkeldam; Nicholas J Greco; Yitzhak Tor
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

4.  Ruthenium complexes that break the rules: structural features controlling dual emission.

Authors:  Edith C Glazer; Douglas Magde; Yitzhak Tor
Journal:  J Am Chem Soc       Date:  2007-06-16       Impact factor: 15.419

Review 5.  Single-Labeled Oligonucleotides Showing Fluorescence Changes Upon Hybridization with Target Nucleic Acids.

Authors:  Gil Tae Hwang
Journal:  Molecules       Date:  2018-01-08       Impact factor: 4.411

Review 6.  Ruthenium polypyridine complexes combined with oligonucleotides for bioanalysis: a review.

Authors:  Shuyu Zhang; Yubin Ding; Hui Wei
Journal:  Molecules       Date:  2014-08-11       Impact factor: 4.411

Review 7.  Applications of Ruthenium Complexes Covalently Linked to Nucleic Acid Derivatives.

Authors:  Marie Flamme; Emma Clarke; Gilles Gasser; Marcel Hollenstein
Journal:  Molecules       Date:  2018-06-22       Impact factor: 4.411

8.  Covalently Functionalized DNA Duplexes and Quadruplexes as Hybrid Catalysts in an Enantioselective Friedel-Crafts Reaction.

Authors:  Surjendu Dey; Andres Jäschke
Journal:  Molecules       Date:  2020-07-08       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.